Chemotherapy following immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: clinical effectiveness and influence of inflammatory and nutritional factors

被引：0
|
作者：
Akihiro Sakai
Koji Ebisumoto
Hiroaki Iijima
Mayu Yamauchi
Takanobu Teramura
Aritomo Yamazaki
Takane Watanabe
Toshihide Inagi
Daisuke Maki
Kenji Okami
机构：
[1] Tokai University,Department of Otolaryngology, Head and Neck Surgery
[2] School of Medicine,undefined
来源：
Discover Oncology | / 14卷
关键词：
Recurrent; Distant metastasis; Head and neck cancer; Immune checkpoint inhibitor; Chemotherapy; Platelet to lymphocyte ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Chemotherapy following immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: clinical effectiveness and influence of inflammatory and nutritional factors
    Sakai, Akihiro
    Ebisumoto, Koji
    Iijima, Hiroaki
    Yamauchi, Mayu
    Teramura, Takanobu
    Yamazaki, Aritomo
    Watanabe, Takane
    Inagi, Toshihide
    Maki, Daisuke
    Okami, Kenji
    [J]. DISCOVER ONCOLOGY, 2023, 14 (01)
  • [2] Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
    Wakasaki, Takahiro
    Manako, Tomomi
    Yasumatsu, Ryuji
    Hara, Hirotaka
    Toh, Satoshi
    Masuda, Muneyuki
    Yamauchi, Moriyasu
    Kuratomi, Yuichiro
    Nishimura, Emi
    Takeuchi, Toranoshin
    Matsuo, Mioko
    Jiromaru, Rina
    Hashimoto, Kazuki
    Komune, Noritaka
    Nakagawa, Takashi
    [J]. PLOS ONE, 2022, 17 (07):
  • [3] Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Sakai, Akihiro
    Iijima, Hiroaki
    Ebisumoto, Koji
    Yamauchi, Mayu
    Teramura, Takanobu
    Yamazaki, Aritomo
    Watanabe, Takane
    Inagi, Toshihide
    Maki, Daisuke
    Okami, Kenji
    [J]. CANCERS, 2023, 15 (07)
  • [4] Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck
    Kacew, Alec J.
    Harris, Ethan J.
    Lorch, Jochen H.
    Schoenfeld, Jonathan D.
    Margalit, Danielle N.
    Kass, Jason, I
    Tishler, Roy B.
    Haddad, Robert, I
    Hanna, Glenn J.
    [J]. ORAL ONCOLOGY, 2020, 105
  • [5] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste-Rotllan, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada-Bouzid, Esma
    Even, Caroline
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 121 : 123 - 129
  • [6] Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Suzuki, Shinsuke
    Toyoma, Satoshi
    Kawasaki, Yohei
    Koizumi, Koh
    Iikawa, Nobuko
    Shiina, Kazuhiro
    Endo, Tentaro
    Abe, Tomoe
    Kouga, Teppei
    Yamada, Takechiyo
    [J]. MEDICINA-LITHUANIA, 2021, 57 (11):
  • [7] Clinical predictors for survival with the addition of chemotherapy in patients with recurrent-metastatic squamous cell carcinoma of the head and neck after progression on immune checkpoint inhibitors
    Issa, M.
    Klamer, B.
    Bhateja, P.
    Karivedu, V.
    Laliotis, G.
    Dibs, K.
    Mladkova, N.
    Pan, X.
    Old, M.
    Gamez, M.
    Grecula, J.
    Jhawar, S.
    Mitchell, D.
    Baliga, S.
    Carrau, R.
    Rocco, J.
    Bonomi, M.
    Blakaj, D.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S797 - S798
  • [8] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
  • [9] Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tanaka, Hideki
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Tanaka, Nobukazu
    Takeshita, Naohiro
    Onaga, Ryutaro
    Hoshi, Yuta
    Wada, Akihisa
    Sato, Masanobu
    Ueda, Yuri
    Tahara, Makoto
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
    Bila, Michel
    Franken, Amelie
    Van Dessel, Jeroen
    Garip, Melisa
    Meulemans, Jeroen
    Willaert, Robin
    Hoeben, Ann
    Vander Poorten, Vincent
    Clement, Paul M.
    [J]. ORAL ONCOLOGY, 2024, 149
12345